PFSA Profusa, Inc.

NEUTRAL Impact: 4/10 EFFECT
Horizon days Filed Mar 4, 2026 Processed 3mo ago SEC 9999999995-26-000710
IPO/offering going effective
Final — all horizons settled through T+60d
PFSA ▼ -63.96% at T+60d
NEUTRAL call ✗ call lost -63.96% · α vs SPY -74.05% · entry $0.9990 → $0.3600
Last close $0.2950 (close Jun 8) · -70.47% from $0.9990 entry
Entry anchored
Mar 3, 03:40 PM ET
via Databento tick
T+1d
+1.10%
call +1.10% · α +1.67%
$1.01
settled 3mo ago
T+5d
-7.11%
call -7.11% · α -5.77%
$0.9280
settled 3mo ago
T+20d
-42.04%
call -42.04% · α -37.63%
$0.5790
settled 2mo ago
T+60d
-63.96%
call -63.96% · α -74.05%
$0.3600
settled 12d ago

Price Chart

Loading chart...

Executive Summary

Profusa, Inc. has announced the effectiveness of its SEC registration statement (File No. 333-293451), allowing the company to proceed with an offering of securities. The filing is an EFFECT notice, indicating that the registration is now active as of March 3, 2026.

Actionable Insight

Traders should monitor for imminent pricing and offering details, which may introduce near-term volatility. The effectiveness creates potential for share dilution if a public offering follows, particularly relevant for the OTC-traded NVACW.

Key Facts

  • SEC Form EFFECT filed by Profusa, Inc. became effective on March 3, 2026.
  • The registration statement (File No. 333-293451) is now effective, permitting the company to issue securities.
  • This is not an IPO but likely a follow-on or shelf offering, given the company's prior existence and name change from NorthView Acquisition Corp in 2021.
  • No specific offering size, price, or share count is disclosed in the EFFECT filing.
  • Company operates in the medical devices sector (SIC 3841) and is headquartered in New York, NY.

Financial Impact

Not specified

dilutionequity capital

Risk Factors

  • Potential for share dilution if a follow-on offering is executed.
  • Uncertainty around offering size, timing, and use of proceeds.
  • OTC listing may limit liquidity and increase volatility upon any offering.

Market Snapshot

Exchange
OTC

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000710
Document: 9999999995-26-000710-index.html9999999995-26-000710
Document: 9999999995-26-000710.txt9999999995-26-000710
4 reports for PFSA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PFSA — sortable, filterable
Type Now
May 15, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$0.4450 $0.3760▼ −15.51%▼ −16.47%$0.2950 (−33.71%)
May 4, 2026
5w ago
Insider Cluster
MIXED ★ 6/10
$0.5570 $0.4800▼ −13.82%▼ −16.76%$0.2950 (−47.04%)
Mar 13, 2026
12w ago
8-K
BEARISH ★ 8/10
$0.9170 $0.5270▲ +42.53%▲ +40.41%$0.2950 (+67.83%)
Mar 4, 2026
14w ago
EFFECT
NEUTRAL ★ 4/10
$0.9990 $0.9280▼ −7.11%▼ −5.77%$0.2950 (−70.47%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 7h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access